VivoSeq
Other

Tonsillectomy

0

Pipeline Programs

4

Active Trials

1

Companies Involved

Tonsillectomy is an early-stage landscape with 0 programs across 1 company. The most active players are Pacira Pharmaceuticals, Inc.

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

73/100

Attrition Rate

22/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

67

clinical trials

Completed40 · 60%
Terminated12 · 18%
Unknown status8 · 12%
Recruiting3 · 4%
Withdrawn3 · 4%
Not yet recruiting1 · 1%

Trial Activity

67 trials

Optimization of Pediatric Tonsillectomy to IMprove AnaLgesia
Recruiting··Phase 4·NCT06576830·440 enrolled
Melatonin vs Midazolam in Children Undergoing Tonsillectomy
Not yet recruiting··Phase 3·NCT07336095·195 enrolled
EXPAREL® for Pain After Tonsillectomy
Completed·MMayo Clinic·Phase 4·NCT02444533·39 enrolled
Magnesium vs Placebo for Tonsillectomy
Completed··Phase 2/3·NCT02218424·60 enrolled
Celecoxib After Tonsillectomy
Completed··Phase 2·NCT02934191·172 enrolled
An Approach to Reduce Uvula Edema After Tonsillectomy
Completed··Phase 4·NCT03079453·30 enrolled
Effect of Ketorolac on Post Adenotonsillectomy Pain
Completed·EEmory University·Phase 4·NCT03467750·63 enrolled
Page 1 of 5

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)